Daniel Abdun-Nabi's Net Worth

$21.6 Million

Estimate Recalculated Apr 17, 2024 04:06PM EST

Who is Daniel Abdun-Nabi?

Daniel Abdun-Nabi has an estimated net worth of $21.6 Million. This is based on reported shares across multiple companies, which include REGENXBIO Inc., Emergent BioSolutions Inc., and Aptevo Therapeutics Inc..

SEC CIK

Daniel Abdun-Nabi's CIK is 0001380187

Past Insider Trading and Trends

2007 was Daniel Abdun-Nabi's most active year for acquiring shares with 26 total transactions. Daniel Abdun-Nabi's most active month to acquire stocks was the month of May. 2007 was Daniel Abdun-Nabi's most active year for disposing of shares, totalling 48 transactions. Daniel Abdun-Nabi's most active month to dispose stocks was the month of May. 2018 saw Daniel Abdun-Nabi paying a total of $4,169,349.86 for 258,711 shares, this is the most they've acquired in one year. In 2018 Daniel Abdun-Nabi cashed out on 257,660 shares for a total of $10,155,799.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REGENXBIO Inc. (RGNX) Snapshot price: $14.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Aug 5
Form 3
—
0
—
—
0
No matching records found

Emergent BioSolutions Inc. (EBS) Snapshot price: $1.63

CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.27%
-14.56K
$58.11
-$846,328.45
142.62K
Scheduled
Mar 4
Form 4
-5.63%
-9.38K
$58.93
-$553,059.45
157.18K
Feb 26 - Feb 28
Form 4
—
0
$39.19
-$1,524,803.18
166.57K
Scheduled
Sep 14 - Sep 17
Form 4
-15.60%
-30.78K
$36.78
-$4,660,430.26
166.57K
Scheduled
Sep 4 - Sep 5
Form 4
-7.41%
-15.79K
$52.11
-$822,614.75
197.34K
Jun 5
Form 4
-3.54%
-7.83K
$51.84
-$405,648.00
213.13K
Mar 9
Form 4
+8.24%
16.82K
$49.86
-$494,755.39
220.95K
Feb 27 - Feb 28
Form 4
—
0
$31.17
-$733,193.82
204.13K
Scheduled
Jan 2
Form 4
—
0
$30.22
-$631,000.00
204.13K
Scheduled
Dec 13
Form 4
—
0
$29.99
-$805,168.76
204.13K
Scheduled
Nov 3
Form 4
—
0
$30.98
-$268,320.00
204.13K
Scheduled
Sep 27
Form 4
—
0
$29.62
-$227,700.00
204.13K
Scheduled
Aug 31
Form 4
-8.50%
-18.96K
$31.02
-$588,256.38
204.13K
Mar 9 - Mar 10
Form 4
+17.36%
32.99K
$30.63
-$189,415.92
223.1K
Feb 28
Form 4
+0.50%
943
$30.63
$28,884.09
190.1K
Feb 27
Form 4
+10.64%
18.2K
$22.90
-$331,829.31
189.16K
Scheduled
Aug 1 - Jan 10
Form 4
-4.84%
-8.70K
$43.74
-$380,494.26
170.97K
Scheduled
Jun 1
Form 4
-4.62%
-8.70K
$42.00
-$365,442.00
179.66K
Scheduled
May 20
Form 4
-4.42%
-8.70K
$40.17
-$349,559.34
188.37K
Scheduled
Apr 18
Form 4
-3.19%
-6.49K
$34.22
-$222,190.46
197.07K
Mar 11
Form 4
-7.82%
-17.28K
$34.48
-$595,664.12
203.56K
Mar 9 - Mar 10
Form 4
+19.14%
35.47K
—
—
220.84K
Mar 1
Form 4
—
0
$28.98
-$1,273,982.71
185.37K
Scheduled
Dec 23 - Dec 24
Form 4
+0.82%
1.5K
$31.01
-$33.67
185.37K
Dec 15
Form 4
-0.51%
-936.00
—
—
183.87K
May 14
Form 4
+16.69%
26.43K
$28.93
-$600,551.37
184.81K
Mar 10 - Mar 12
Form 4
+0.91%
4.34K
$22.53
-$8.79
483.32K
Dec 24
Form 4
+0.33%
506
$18.44
$9,330.64
154.04K
May 31
Form 4
-1.42%
-2.25K
$27.06
-$60,830.88
155.53K
Mar 14
Form 4
-1.88%
-3.02K
$27.15
-$82,020.15
157.78K
Mar 12
Form 4
+55.28%
57.25K
$28.09
-$122,107.23
160.8K
Mar 11
Form 4
+0.73%
749
$19.08
$14,290.92
103.37K
Nov 30
Form 4
+4.80%
4.61K
$10.13
$46,729.69
100.62K
Nov 7
Form 4
+0.84%
800
$12.07
$9,656.00
96.01K
May 31
Form 4
-2.31%
-2.25K
$14.46
-$32,506.08
95.21K
Mar 14
Form 4
+56.86%
35.33K
$14.90
-$82,025.55
97.46K
Mar 8 - Mar 12
Form 4
+4.41%
2.62K
$12.97
$5.63
62.15K
Dec 27
Form 4
+77.90%
26.07K
$16.05
-$35,069.25
59.52K
Mar 13 - Mar 14
Form 4
-6.44%
-2.30K
$14.49
-$33,370.47
33.46K
Mar 8
Form 4
-12.41%
-5.07K
$16.77
-$2,832,765.43
35.76K
May 31 - Jun 1
Form 4
+105.90%
21K
—
—
40.83K
Mar 15
Form 4
-10.45%
-2.31K
$21.15
-$48,962.25
19.83K
Mar 8
Form 4
-42.91%
-18.15K
$18.77
-$340,644.00
24.14K
Scheduled
Jul 28 - Jul 29
Form 4
+109.90%
22.14K
—
—
42.3K
Mar 9
Form 4
-9.03%
-2.00K
$16.27
-$32,543.00
20.15K
Aug 18
Form 4
-17.90%
-11.00K
$17.21
-$189,475.00
50.45K
Aug 11
Form 4
—
0
—
—
0
Mar 10
Form 4
-18.85%
-7.70K
$20.01
-$154,105.36
33.15K
Nov 11
Form 4
—
0
—
—
0
Mar 11
Form 4
+5.73%
2.21K
$6.28
-$34,487.30
40.85K
Scheduled
Jun 28 - Jun 29
Form 4
+1.83%
2.1K
$6.11
-$33,639.42
116.9K
Scheduled
Jun 26 - Jun 27
Form 4
+3.66%
2.53K
$5.89
-$27,254.08
71.52K
Scheduled
Jun 22 - Jun 25
Form 4
+9.64%
2.99K
$5.97
-$23,798.34
34.01K
Scheduled
Jun 20 - Jun 21
Form 4
+9.07%
2.58K
$6.35
-$31,648.50
31.02K
Scheduled
Jun 18 - Jun 19
Form 4
+9.71%
2.52K
$5.86
-$26,916.00
28.44K
Scheduled
Jun 14 - Jun 15
Form 4
+25.26%
5.23K
$5.66
-$37,436.78
25.92K
Scheduled
Jun 12 - Jun 13
Form 4
+19.38%
3.36K
$5.68
-$24,175.35
20.7K
Scheduled
Jun 8 - Jun 11
Form 4
+43.91%
5.29K
$5.84
-$21,877.84
17.34K
Scheduled
Jun 6 - Jun 7
Form 4
+50.42%
4.04K
$6.18
-$17,941.02
12.05K
Scheduled
Jun 4 - Jun 5
Form 4
+110.18%
4.2K
$6.42
-$19,550.29
8.01K
Scheduled
May 31 - Jun 1
Form 4
∞
3.81K
$6.59
-$20,052.60
3.81K
Scheduled
May 29 - May 30
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Nov 20
Form 3
—
0
—
—
0
No matching records found

Aptevo Therapeutics Inc. (APVO) Snapshot price: $0.156

Board Directors

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+74.90%
3.57K
—
—
8.34K
Aug 9
Form 4
+6.64%
297
—
—
4.77K
Jun 1 - Jun 2
Form 4/A
—
0
—
—
0
Form 4
—
0
—
—
0
Aug 9
Form 4
+3.82%
298
—
—
8.11K
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jul 27
Form 4
+17.98%
16.67K
$0.90
$15,000.30
109.35K
Jun 25
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Aug 3
Form 3
—
0
—
—
0
No matching records found